Silencing of lncRNA UCA1 Reverses Doxorubicin Resistance of Breast Cancer Through Inhibiting PI3K/AKT/mTOR Signaling Pathway
Article in ChemistrySelect (May 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in ChemistrySelect (May 2024)
Article in Frontiers in Oncology (March 2024)
Article in Heliyon (November 2023)